These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 16408748)
1. [Morphological and functional alterations of ear in lysosomal neuraminidase gene deficient mouse]. Guo YK; Xie DH; Yang XM Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Nov; 40(11):824-9. PubMed ID: 16408748 [TBL] [Abstract][Full Text] [Related]
2. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency]. Guo YK; Xie DH; Yang XM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682 [TBL] [Abstract][Full Text] [Related]
3. C3H/HeJ mouse model for spontaneous chronic otitis media. MacArthur CJ; Hefeneider SH; Kempton JB; Trune DR Laryngoscope; 2006 Jul; 116(7):1071-9. PubMed ID: 16826039 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the mouse model for acute otitis media. MacArthur CJ; Hefeneider SH; Kempton JB; Parrish SK; McCoy SL; Trune DR Hear Res; 2006 Sep; 219(1-2):12-23. PubMed ID: 16887307 [TBL] [Abstract][Full Text] [Related]
5. Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Wu X; Steigelman KA; Bonten E; Hu H; He W; Ren T; Zuo J; d'Azzo A Biochim Biophys Acta; 2010 Feb; 1802(2):259-68. PubMed ID: 19857571 [TBL] [Abstract][Full Text] [Related]
6. Sh3pxd2b mice are a model for craniofacial dysmorphology and otitis media. Yang B; Tian C; Zhang ZG; Han FC; Azem R; Yu H; Zheng Y; Jin G; Arnold JE; Zheng QY PLoS One; 2011; 6(7):e22622. PubMed ID: 21818352 [TBL] [Abstract][Full Text] [Related]
7. Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources. Parker LL; Gao J; Zuo J Brain Res; 2006 May; 1091(1):235-42. PubMed ID: 16630581 [TBL] [Abstract][Full Text] [Related]
8. Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse. Kamphoven JH; de Ruiter MM; Winkel LP; Van den Hout HM; Bijman J; De Zeeuw CI; Hoeve HL; Van Zanten BA; Van der Ploeg AT; Reuser AJ Neurobiol Dis; 2004 Jun; 16(1):14-20. PubMed ID: 15207257 [TBL] [Abstract][Full Text] [Related]
9. Auditory development in progressive motor neuronopathy mouse mutants. Volkenstein S; Brors D; Hansen S; Berend A; Mlynski R; Aletsee C; Dazert S Neurosci Lett; 2009 Nov; 465(1):45-9. PubMed ID: 19735697 [TBL] [Abstract][Full Text] [Related]
10. Progressive hearing loss in mice carrying a mutation in the p75 gene. Sato T; Doi K; Taniguchi M; Yamashita T; Kubo T; Tohyama M Brain Res; 2006 May; 1091(1):224-34. PubMed ID: 16564506 [TBL] [Abstract][Full Text] [Related]
11. Mutant ICR mouse, kuru2, manifests hearing impairment and abnormal behavior. Hasegawa N; Watanabe M; Inoue H; Kobayashi T; Kojima H; Manome Y In Vivo; 2002; 16(5):349-60. PubMed ID: 12494877 [TBL] [Abstract][Full Text] [Related]
12. Analysis of auditory function using brainstem auditory evoked potentials and auditory steady state responses in infants with perinatal brain injury. Moreno-Aguirre AJ; Santiago-Rodríguez E; Harmony T; Fernández-Bouzas A; Porras-Kattz E Int J Audiol; 2010 Feb; 49(2):110-5. PubMed ID: 20151885 [TBL] [Abstract][Full Text] [Related]
13. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase. Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988 [TBL] [Abstract][Full Text] [Related]
15. Mcph1-deficient mice reveal a role for MCPH1 in otitis media. Chen J; Ingham N; Clare S; Raisen C; Vancollie VE; Ismail O; McIntyre RE; Tsang SH; Mahajan VB; Dougan G; Adams DJ; White JK; Steel KP PLoS One; 2013; 8(3):e58156. PubMed ID: 23516444 [TBL] [Abstract][Full Text] [Related]
16. Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia. Uchihara T; Ohashi K; Kitagawa M; Kurata M; Nakamura A; Hirokawa K; Kasuga T; Kobayashi T Acta Neuropathol; 2010 Jan; 119(1):135-45. PubMed ID: 19415310 [TBL] [Abstract][Full Text] [Related]
17. Short-term, high dose enzyme replacement therapy in sialidosis mice. Wang D; Bonten EJ; Yogalingam G; Mann L; d'Azzo A Mol Genet Metab; 2005 Jul; 85(3):181-9. PubMed ID: 15979029 [TBL] [Abstract][Full Text] [Related]
18. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Bonten EJ; Arts WF; Beck M; Covanis A; Donati MA; Parini R; Zammarchi E; d'Azzo A Hum Mol Genet; 2000 Nov; 9(18):2715-25. PubMed ID: 11063730 [TBL] [Abstract][Full Text] [Related]
19. Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model. Kavanagh KR; Parham K; Schoem SR Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):238-41. PubMed ID: 19289700 [TBL] [Abstract][Full Text] [Related]
20. Sensorineural hearing loss in insulin-like growth factor I-null mice: a new model of human deafness. Cediel R; Riquelme R; Contreras J; Díaz A; Varela-Nieto I Eur J Neurosci; 2006 Jan; 23(2):587-90. PubMed ID: 16420467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]